RhumbLine Advisers’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $117K | Buy |
|
|||||
|
2022
Q4 | $70K | Sell |
|
|||||
|
2022
Q3 | $148K | Buy |
|
|||||
|
2022
Q2 | $174K | Buy |
|
|||||
|
2022
Q1 | $292K | Sell |
|
|||||
|
2021
Q4 | $373K | Buy |
|
|||||
|
2021
Q3 | $316K | Buy |
|
|||||
|
2021
Q2 | $282K | Buy |
|
|||||
|
2021
Q1 | $286K | Sell |
|
|||||
|
2020
Q4 | $202K | Buy |
|
|||||
|
2020
Q3 | $206K | Sell |
|
|||||
|
2020
Q2 | $201K | Buy |
|
|||||
|
2020
Q1 | $132K | Buy |
|
|||||
|
2019
Q4 | $221K | Buy |
|
|||||
|
2019
Q3 | $83K | Buy |
|
|||||
|
2019
Q2 | $114K | Buy |
|
|||||
|
2019
Q1 | $121K | Buy |
|
|||||
|
2018
Q4 | $65K | Buy |
|
|||||
|
2018
Q3 | $89K | Sell |
|
|||||
|
2018
Q2 | $113K | Buy |
|
|||||
|
2018
Q1 | $286K | Buy |
|
|||||
|
2017
Q4 | $134K | Buy |
|